Invivyd Future Growth
Future criteria checks 5/6
Invivyd is forecast to grow earnings and revenue by 72.2% and 56.9% per annum respectively. EPS is expected to grow by 72.7% per annum. Return on equity is forecast to be -297% in 3 years.
Key information
72.2%
Earnings growth rate
72.7%
EPS growth rate
| Biotechs earnings growth | 28.3% |
| Revenue growth rate | 56.9% |
| Future return on equity | -297.0% |
| Analyst coverage | Low |
| Last updated | 21 Nov 2024 |
Recent future growth updates
Recent updates
Here's Why We're Watching Invivyd's (NASDAQ:IVVD) Cash Burn Situation
Jul 16
Is Invivyd (NASDAQ:IVVD) In A Good Position To Invest In Growth?
Mar 29We're Keeping An Eye On Invivyd's (NASDAQ:IVVD) Cash Burn Rate
Oct 24We're Keeping An Eye On Invivyd's (NASDAQ:IVVD) Cash Burn Rate
Jul 04Will Invivyd (NASDAQ:IVVD) Spend Its Cash Wisely?
Mar 19Is Invivyd (NASDAQ:IVVD) In A Good Position To Deliver On Growth Plans?
Nov 19Invivyd appoints interim CFO, makes headcount changes
Oct 13Adagio Therapeutics changes name to Invivyd, generates COVID-19 antibodies
Sep 12Adagio Therapeutics GAAP EPS of -$0.47
Aug 15We're Keeping An Eye On Adagio Therapeutics' (NASDAQ:ADGI) Cash Burn Rate
Jul 30Adagio names David Hering as permanent CEO and Director
Jul 05Adagio's Round Trip
Mar 02We're Interested To See How Adagio Therapeutics (NASDAQ:ADGI) Uses Its Cash Hoard To Grow
Feb 19Adagio: A COVID-19 Play With Big Potential On Possible Treatment And Prevention
Feb 16Adagio Therapeutics: The Market Is Too Crowded For Its Lead Drug Candidate
Nov 29Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 336 | 116 | 148 | 149 | 4 |
| 12/31/2025 | 165 | 0 | 29 | 28 | 5 |
| 12/31/2024 | 26 | -186 | -174 | -174 | 4 |
| 9/30/2024 | 12 | -225 | -192 | -192 | N/A |
| 6/30/2024 | 2 | -204 | -187 | -186 | N/A |
| 3/31/2024 | N/A | -207 | -182 | -182 | N/A |
| 12/31/2023 | N/A | -199 | -174 | -173 | N/A |
| 9/30/2023 | N/A | -170 | -163 | -161 | N/A |
| 6/30/2023 | N/A | -175 | -184 | -182 | N/A |
| 3/31/2023 | N/A | -176 | -204 | -202 | N/A |
| 12/31/2022 | N/A | -241 | -222 | -220 | N/A |
| 9/30/2022 | N/A | -280 | -246 | -246 | N/A |
| 6/30/2022 | N/A | -295 | -244 | -244 | N/A |
| 3/31/2022 | N/A | -289 | -220 | -220 | N/A |
| 12/31/2021 | N/A | -227 | -185 | -185 | N/A |
| 9/30/2021 | N/A | -208 | -135 | -135 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: IVVD is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.6%).
Earnings vs Market: IVVD is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: IVVD is expected to become profitable in the next 3 years.
Revenue vs Market: IVVD's revenue (56.9% per year) is forecast to grow faster than the US market (9% per year).
High Growth Revenue: IVVD's revenue (56.9% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: IVVD is forecast to be unprofitable in 3 years.